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The D-shuttle dosimeter technique is a convenient approach for estimating the radiation
dosimetry in a positron emission tomography (PET) study that employs multiple  D-
shuttle dosimeters attached to the body surface of a patient. To bring this technique into
clinical usage, it is very important to evaluate its performance by investigating the bias
associated with D-shuttle dosimeter positioning and by comparing the estimates with
those of the whole-body dynamic PET imaging technique.  The torso cavity and six
spheres of the NEMA body phantom were filled with 18F-FDG solution, and then, the
phantom was imaged for one hour. We assumed the mis-located positioning of the D-
shuttle dosimeters by shifting them in the z-direction (upper) in a range of 1 to 5 cm
from  the  original  positions.  The  cumulative  radioactivities,  absorbed  doses,  and
effective dose were estimated using accurate and mis-located positions of the D-shuttle
dosimeters. For comparison, the cumulative radioactivities were also estimated from the
PET images,  and then,  the  absorbed  doses  and effective  dose  were  computed.  The
maximum bias  of  the  average  estimated  cumulated  radioactivities  and  the  effective
doses were -15.0 % and -19.7 % for the 1 cm shifted positions, respectively. The ratios
of absorbed doses obtained from D-shuttle and PET measurement  against  the actual
values were between 0.9 and 1.3, and 0.7 and 1.0, respectively. The bias associated with
the  D-shuttle  dosimeter  positions  was  significant  and probably  consistent,  and both
dosimetric techniques exhibited good performance in this phantom study. 
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Positron  emission  tomography  (PET)  is  a  gamma  imaging  technique  that  enables
visualization of metabolic processes in the human body. PET imaging is based on the
simultaneous detection of two 511 keV annihilation photons that arise after positron-
electron  annihilation.  In  practice,  a  significant  amount  of  radiopharmaceuticals
synthesized from radionuclides (e.g.,  oxygen-15, fluorine-18, carbon-11, or nitrogen-
13) is administered to the patient. PET systems have sensitive detector panels to capture
gamma rays  emitted  from positron-emitting  radiopharmaceuticals,  and  thus  produce
three-dimensional  functional  images of the body on the computer  [1,2].  An internal
radiation dosimetric study is necessary to ensure the safe use of PET technology and to
protect patients when they are exposed to ionizing radiation.  In this regard, Medical
Internal Radiation Dose (MIRD), International Commission on Radiological Protection
(ICRP),  International  Atomic  Energy Agency and European Association  of  Nuclear
Medicine have devised several policy statements,  such as guidelines,  methodologies,
models,  safety reports,  improved dose regimes,  and dedicated  low dose whole-body
PET protocols  [3,  4,  5,  6]. However, internal radiation doses delivered to the patients
from PET imaging examinations still remain a matter of concern [7,8]. 
Internal  radiation  dose  calculations  in  nuclear  medicine  widely  use  the
methodologies and formulations provided by the MIRD committee of the society of
nuclear  medicine.  In  the  MIRD  computational  methodology,  doses  in  the  internal
organs of patients are simplified as a function of the cumulative radioactivity and of the


























dose to the target organ per unit of cumulative radioactivity in the source organ, which
can be calculated using an MIRD reference phantom and Monte Carlo simulation. In the
last decade, cumulative radioactivity estimation by whole-body dynamic PET imaging
technique has been widely applied in nuclear medicine [10]. In this technique, after the
administration  of  the  radiopharmaceutical  to  patient,  the  whole-body  dynamic  PET
imagining  protocols  are  repeated  to  obtain  the  conspicuous  images  of  the  internal
organs. Whole-body dynamic PET images are then reconstructed with attenuation and
scattering corrections. Three-dimensional volumes of interest (VOIs) are hand-drawn on
the PET transaxial or coronal slices of the frame where the organ is used to form time
activity curves for calculating the cumulative radioactivity in the source organ [11]. A
series of whole-body dynamic PET scans is difficult  to perform routinely and takes
much longer than usual clinical PET studies; this can make the patient uncomfortable
[12].  As  an  alternative,  our  previous  study  [13] introduced  the D-shuttle  dosimeter
technique as a convenient approach for estimating the cumulative radioactivity for each
source organ in a PET study by using multiple D-shuttle dosimeters  attached to the
body  surface  of  a  patient.  We  also  performed  a  validation  study  using  a  National
Electrical Manufacturers Association (NEMA) body phantom. In this technique, a few
D-shuttle dosimeters are placed on the patient’s  body surface during a PET study to
obtain  information  on  the  body  surface  doses,  as  these  doses  are  connected  to
cumulative  radioactivities  in  multiple  source  organs  considering  gamma  ray
contributions. The R-value is the radiation dose at the D-shuttle dosimeter position per
unit of cumulative radioactivity in the source organ and can be computed by a Monte
Carlo simulation with a mathematical phantom. Radioactivities of the source organs can


























matrix  and  the  body  surface  dose  by  using  the  maximum-likelihood  expectation-
maximization (MLEM) algorithm. Because a D-shuttle dosimeter releases a dose every
2 min, the cumulative radioactivity in a source organ can then be calculated from the
radioactivity at 2-min intervals. 
Internal radiation dose assessment by D-shuttle dosimeter technique depends on
the model of the human body and its organs, and the D-shuttle dosimeter positioning on
the human body against the source organ. To compute the R-value at each D-shuttle
dosimeter  position  by  Monte  Carlo  simulation,  we  need  to  determine  the  accurate
positions of the D-shuttle dosimeters and the specified internal organs treated as the
source organ of the patient.  In our previous study  [13], the determination of the D-
shuttle dosimeters positioning on the NEMA body phantom surface and the position of
source organs (i.e., the torso cavity and six spheres) were accurate. Hence, we obtained
good  results  in  all  variants.  However,  in  the  clinical  PET study,  although  we  can
accurately place the D-shuttle dosimeters on the patient body surface, it is not possible
to  measure  the  positions  of  the  internal  organs  without  performing  computed
tomography (CT) or magnetic resonance imaging (MRI) measurements. If CT and MRI
procedures are not available, the accurate position of D-shuttle dosimeters on the patient
body surface against the source organs may not be possible. The aim of this study is to
investigate  how  much  bias  would  be  obtained  if  the  determinations  of  D-shuttle
dosimeter positions are mis-located. In this paper, we also compared two approaches to
estimate the cumulative radioactivity, namely whole-body dynamic PET imaging and
the  D-shuttle  dosimeter  technique.  We  estimated  the  cumulative  radioactivities,
absorbed doses, and effective dose for the torso cavity and six spheres embedded in the


























2 Materials and Methods 
2.1 D-shuttle dosimeter technique  
In our previous paper [13], we addressed the D-shuttle dosimeter technique in detail for
estimating the internal radiation dosimetry in PET study. According to the D-shuttle
dosimeter technique, the  body surface dose at the D-shuttle  dosimeter  position due to
gamma decay in source organs can be expressed by the following formula: 
    d i (t )=Ri ,1 . A1 ( t )+R i ,2 . A2 (t )+R i ,3 . A3 (t )
              =∑
j
R i , j . A j (t )                                                                                                    (1)
where  di(t) is the body surface dose at the  ith D-shuttle  dosimeter  position at time  t,
A j ( t ) is the radioactivity at time t in the jth source organ, and Ri,j is radiation dose at the
ith  D-shuttle  dosimeter  position  per  unit  cumulative  radioactivity  in  the  jth  source
organ. The R-value can be expressed by the following formula: 
Ri , j=∑
k
ψ k ( E )(μ en(k)(E)ρ )                                                                                         (2)   
ψk ( E ) is  the  photon  fluence  as  a  function  of  photon  energy  per  unit  cumulative
radioactivity in the source organ and μen(k)ρ−1 is the mass energy absorption coefficient.
μen(k) is the mass energy attenuation coefficient as a function of the photon energy, and ρ
is the density of the medium. The mass energy absorption coefficient can be taken from
the International Commission on Radiation Units and Measurements (ICRU) Report 44
























Radioactivity A(t) at time t in a source organ can be estimated from Ri,j values and D-
shuttle dosimeter measurements to solve Eq. (1) iteratively using the MLEM algorithm.
The cumulative radioactivity in a source organ can then be estimated from the obtained
radioactivity A(t) at time t.
2.2 Error evaluation associated with mis-location of D-shuttle dosimeters 
In our previous study [13], we determined the original positions of all eleven D-shuttle
dosimeters carefully in Cartesian co-ordinates against the source organ; the torso cavity
and six spheres of the NEMA body phantom were treated as the source organs, and the
D-shuttle dosimeters were attached to the surface of the NEMA body phantom, which
was  filled  with  18F-FDG  solution.  Radioactivity  concentrations  present  in  the  torso
cavity  and  six  spheres  were  0.00165  MBq/mL  and  1.32  MBq/mL,  respectively.  A
mathematical  NEMA body  phantom is  modelled in  the  Heavy Ion  Transport  Code
System (PHITS) Monte Carlo simulation code [15,16,17], which was used to compute
the R-values at the D-shuttle dosimeter positions. In the current study, we assumed the
mis-located positions of the D-shuttle dosimeters by shifting them in the z-direction
(upper) in a range of 1 to 5 cm from the original positions. Figure 1 depicts the eleven
D-shuttle  dosimeter  positions  (D1  to  D11)  in  Cartesian  co-ordinates  on  the
mathematical NEMA body phantom. The 5-cm shifted positions of all eleven D-shuttle
dosimeters  on the NEMA body phantom surface in the z-direction (upper) from the
original  positions  are  also  shown  in  Figure  1.  The  green  and  red  colors  (points)
represent the accurate positions and the 5-cm shifted (mis-located) positions of the D-


























Fig. 1 Mathematical NEMA body phantom in Monte Carlo simulation with accurate and
mis-located positions of the D-shuttle dosimeters (D) in the Cartesian co-ordinates; the
green and red colors (points) show the accurate positions and the 5-cm shifted positions,
respectively.   
The length, width, and interior height of the NEMA body phantom in the x-, y-,
and z-directions are 30.0 cm, 23.0 cm, and 19.4 cm, respectively. The distance between
the  center  of  each  sphere  and  inside  surface  of  the  mounting  plate  is  7  cm.  The
thicknesses of torso wall, superior, bottom and top lid are 0.3 cm, 1.0 cm, 1.1 cm and
2.0 cm, respectively  [16,17].  We determined the position of six spheres in the torso
cavity based on the above-mentioned phantom geometry.  Figure 2 shows the lateral
(XY plane)  view at  z  = 13.5 cm in  the  mathematical  phantom,  where  regions  1–6
represent the position of the six spheres with 37 mm, 28 mm, 22 mm, 17 mm, 13 mm,



















Fig. 2 The lateral view at z = 13.5 cm of the NEMA body phantom in PHITS; red color
represents the position of six spheres in torso, with inner diameters of (1) 37 mm, (2) 28
mm, (3) 22 mm, (4) 17 mm, (5) 13 mm, and 6) 10 mm; and x, y, z are the three-
dimensional positions and r is the radius of the spheres (units are in cm).
The PHITS Monte Carlo simulation yields the photon energy fluence at each D-
shuttle dosimeter position for each source organ. We performed a Monte Carlo (PHITS)
simulation using 511 keV primary energy, 60–700 keV energy range, 100 energy bins,
the position of D-shuttle dosimeters,  and 107 history numbers. We calculated the R-
values  at  every  accurate  and  mis-located  position  for  each  source  organ  from  the
obtained photon energy fluence using Eq. (2). The body surface doses at mis-located
positions of D-shuttle dosimeters were estimated from the actual radioactivity and R-
values at  mis-located D-shuttle  dosimeter  positions by solving the dose-radioactivity
formula  (see  Eq.  1).  The  cumulative  radioactivity  in  each  source  organ  was  then
estimated using the MLEM algorithm based on the obtained body surface doses at mis-
located D-shuttle dosimeter positions and the R-values at original D-shuttle dosimeter
                       (x         y       z          r)
37 mm sphere (-5.72, -3.5, 13.5, 1.85)
28 mm sphere (-2.86, -8.45, 13.5, 1.4)
22 mm sphere (2.86, -8.45, 13.5, 1.1)
17 mm sphere (5.72, -3.5, 13.5, 0.85)
13 mm sphere (2.86, 1.45, 13.5, 0.65)
10 mm sphere (-2.86, 1.45, 13.5, 
0.50)
Units in cm




















positions. Absorbed doses for each mis-located position of D-shuttle dosimeters were
calculated  using  the  obtained  cumulative  radioactivities  in  the  torso  cavity  and  six
spheres according to MIRD method. The effective dose for each mis-located position
was  calculated  in  accordance  with  ICRP  103  [18].  The  cumulative  radioactivities,
absorbed doses, and effective doses were estimated for ‘‘n’’ number of mis-located D-
shuttle dosimeters, where n = 1, 2, 3, 4,…….11. We also identified the dosimeters that
were mis-located in this study. The D-shuttle dosimeters, namely, D1, D1 to D2, D1 to
D3, D1 to D4, D1 to D5,………, and D1 to D11 were separately mis-located in a range
of 1 to 5 cm in the z-direction (upper) from the original positions. The actual cumulative
radioactivities and absorbed doses in the torso cavity and six spheres of the NEMA
body phantom were also calculated from the known radioactivity concentrations and
inner volumes.
Bias (%) in the cumulative radioactivities, average cumulative radioactivities of
the  six  spheres  and  torso  cavity,  absorbed  doses  and  effective  doses  were  then
calculated  based on the  estimated  (i.e.,  inaccurate  results  due  to  mis-location  of  D-
shuttle dosimeters) and actual cumulative radioactivities and absorbed doses in the torso
cavity and six spheres of the NEMA body phantom.  
2.3 PET measurement
Body surface dose measurements by D-shuttle dosimeters were carried out during the
PET study using an Eminence STARGATE PET scanner (Shimadzu, Kyoto, Japan) at
the Cyclotron and Radioisotope Center, Tohoku University, Japan. The PET component


























consists of 9 × 10 arrays of 2.45 × 5.1 × 30 mm3 gadolinium oxyorthosilicate (GSO)
crystal elements. This gives an axial PET field of view of 20.8 cm. The detector ring
diameter is 60.0 cm [19]. After preparing the NEMA body phantom, the phantom was
placed over the patient’s bed and then imaged for one hour (Figure 3). A transmission
scan  was  performed  with  a  Cesium-137  source  with  740  MBq  radioactivity  for
attenuation  correction  of  the  emission  data  just  before  the  emission  scan.  All  PET
images were recorded in digital imaging and communications in medicine (DICOM)
format.    
A mathematical NEMA body phantom was used to compute the S-values for the
torso cavity and six spheres. Because the Monte Carlo simulation yields the total energy
deposition in each source organ for photons emitted from various source organs, we
performed a PHITS simulation using 511 keV primary energy and 107 history numbers.
We calculated the S-values in the torso cavity and six spheres from the obtained energy
deposition and the self-absorbed dose per radioactive decay (i.e., self S-value) for the


















Fig. 3 Positioning of D-shuttle dosimeters and NEMA body phantom imaging set up as
performed in this PET study. 
The PET image analysis was performed using a medical image data examiner
[20] (AMIDE 1.0.4) (Figure 4). Three-dimensional volumes of interest (VOIs) of each
source organ were hand-drawn on the PET transaxial or coronal slices of the emission
frame  to  obtain  the  radioactivity  concentration  in  each  source  organ.  Cumulative
radioactivities in the torso cavity and six spheres of the NEMA body phantom were
calculated using the estimated radioactivity concentrations. The absorbed doses to these














   
Fig. 4 Super imposed images of transmission and emission scans. The PET images; a)
coronal  image  where  two  spots  indicate  the  37  mm  and  17  mm  spheres,  and  b)
transaxial image where six spots indicate the six spheres of the NEMA body phantom
with inner diameters of 37 mm, 28 mm, 22 mm, 17 mm, 13 mm, and 10 mm.   
2.4 D-shuttle measurement
The radioactivity  A(t) at each two-minute interval over a one-hour total dose time for
each source organ was estimated iteratively using the MLEM algorithm based on body
the surface  doses,  as  measured  by the  D-shuttle  dosimeter,  and the R-values  at  the
accurate  D-shuttle  dosimeter  positions  obtained  by  the  PHITS  simulation.  For  the
MLEM calculation, a uniform initial guess of 1010 Bq and 40 iterations were assigned to
solve the dose-radioactivity formula (see Eq. 1) iteratively. Cumulative radioactivities in
the torso cavity and six spheres were estimated from the radioactivity at two-minute
intervals in each source organ. The doses absorbed to these compartments of the NEMA


























2.5 Effective dose calculation
According to  ICRP 103,  the  effective  dose  was  estimated  from the  absorbed doses
obtained from both measurements (i.e., PET measurement and D-shuttle measurement).
In this phantom study, we considered the same weighting factor for the torso cavity and
six spheres, and the sum of the weighting factors is 1.
3 Results   
  
The PHITS Monte Carlo technique was employed to simulate  the S-value from the
source organ to the target organ. The S-value results of the torso cavity and six spheres
of the NEMA body phantom for 18F-FDG radiotracer are shown in Table 1.
Table 1. S-values [mGy/MBq.s] of the torso cavity and six spheres of the NEMA body
phantom  from  the  source  organ  to  the  target  organ  for  the  18F  positron-  emitting

















37 mm sphere 1.8E-03 1.3E-05 3.7E-06 2.7E-06 3.7E-06 1.3E-05 5.0E-06
28 mm sphere 1.4E-05 4.0E-03 1.3E-05 3.7E-06 2.7E-06 3.7E-06 4.9E-06
22 mm sphere 3.7E-06 1.3E-05 8.1E-03 1.3E-05 3.7E-06 2.6E-06 5.0E-06
17 mm sphere 2.7E-06 3.8E-06 1.3E-05 1.8E-02 1.3E-05 3.8E-06 5.5E-06
13 mm sphere 3.6E-06 2.6E-06 3.6E-06 1.2E-05 3.7E-02 1.2E-05 5.2E-06



















Torso cavity 5.3E-06 5.2E-06 5.3E-06 5.7E-06 5.8E-06 5.8E-06 8.8E-06
Figures  5  and  6  illustrate  the  bias  (%)  in  the  cumulative  radioactivity  and  in  the
absorbed dose of the torso cavity and six spheres associated with D-shuttle dosimeters
mis-positioning in a range of 1 to 5 cm in the z-direction (upper) from the original
positioning on the NEMA body phantom surface. In these figures, the red color filled
circles represent the average cumulative radioactivity and the average absorbed dose
(i.e.,  effective dose) of the torso cavity and six spheres. The x-axis of these figures
indicates the number of mis-located D-shuttle dosimeters and identifies the D-shuttle
dosimeters which ones were mis-located. The positive and negative values of the y-axis















             
Fig. 5  Box plots of the bias (%) in the cumulative radioactivity of the torso cavity and
six spheres associated with the mis-location of D-shuttle dosimeters; bias due to a) 1 cm






cm mis-location in the z-direction (upper) from the original positions. D1, D1-D2, D1-
D3,…., D1-D11 indicate that one (i.e., D1), two (i.e., D1 and D2), three (i.e., D1, D2
and  D3),……,  eleven  (i.e.,  D1  to  D11)  D-shuttle  dosimeters  were  mis-located,
respectively. Red filled circle represents the average cumulative radioactivity.    







            
Fig. 6  Box plots of the bias (%) in the absorbed dose of the torso cavity and six spheres
associated  with  the  mis-location  of  D-shuttle  dosimeters;  bias  due to  a)  1  cm mis-
location, b) 2 cm mis-location, c) 3 cm mis-location, d) 4 cm mis-location, and e ) 5 cm
mis-location in the z-direction (upper) from the original positions. D1, D1-D2, D1-D3,








D3),……, eleven (i.e., D1 to D11) D-shuttle dosimeters were mis-located, respectively.
Red filled circles represent average absorbed doses. 
The actual and estimated cumulative radioactivities in the torso cavity and six
spheres embedded in the NEMA body phantom are tabulated in Table 2. Absorbed dose
estimates for all seven compartments and effective dose from 18F-FDG are summarized
in  Table  3.  The  estimated  cumulative  radioactivities,  absorbed  doses,  and  effective
doses obtained from PET and D-shuttle measurements were very close to the actual
values (see Table 2 and 3). Figure 7 represents the ratios of absorbed dose estimates to
the torso cavity  and six spheres obtained from the D-shuttle  measurement  and PET
measurement against the actual value. Green and red colors represent the ratios of the
absorbed doses obtained from the D-shuttle and PET measurements, respectively.    
Table 2. The actual and estimated cumulative radioactivities in the torso cavity and six
spheres of the NEMA body phantom [kBq.h/MBq]  
Source organ Actual cumulative
radioactivity 
Estimated cumulative radioactivity 
PET measurement D-shuttle measurement
37 mm sphere 1168 1118 1111
28 mm sphere 508 478 529
22 mm sphere 245 210 239
17 mm sphere 110 92.3 140
13 mm sphere 51.9 41.8 49.8
10 mm sphere 23.5 17.3 29.1


















Table  3.  Absorbed  dose  estimate  [mGy/MBq]  to  each  fillable  compartment  and
effective dose [mSv/MBq] from 18F-FDG 
Target organs Actual PET measurement D-shuttle measurement
37 mm sphere 7.64 7.31 7.27
28 mm sphere 7.40 6.96 7.68
22 mm sphere 7.17 6.17 7.02
17 mm sphere 7.01 5.89 8.95
13 mm sphere 6.87 5.54 6.60
10 mm sphere 6.78 5.04 8.43
Torso cavity 0.057 0.054 0.058































































Fig.  7  Absorbed  dose  ratios  between  the  PET and  D-shuttle  measurements  against









Our previous  study  [13] demonstrated  a validation  study of the D-shuttle  dosimeter
technique  by using a  NEMA body phantom that  contained six spherical  radioactive
sources and background radioactivity. In the validation study, we did not investigate the
bias of the estimated internal dosimetry due to the inaccurate determination of the D-
shuttle  dosimeter  positioning on the  NEMA body phantom surface.  Moreover,  it  is
important  to  compare  the  dosimetric  approach  with  the  whole-body  dynamic  PET
imaging technique. Consequently, our current study was performed to investigate the
above-mentioned issues with our D-shuttle dosimeter technique.   
OLINDA provides the tables of MIRD S-values for all source and target organs
for a given phantom and radionuclide [21]. To perform the error evaluation of D-shuttle
dosimeter  technique  and  the  comparison  study  of  the  internal  radiation  dosimetry
between D-shuttle measurement and PET measurement using the MIRD schema, the S-
values of the torso cavity and six spheres of the NEMA body phantom were computed
by PHITS Monte Carlo code (see Table 1) instead of the OLINDA/EXM computer
software,  as the OLINDA/EXM does not provide the S-values for the NEMA body
phantom.
 The cumulative radioactivities and absorbed doses in the torso cavity and six
spheres embedded in the NEMA body phantom were estimated through the D-shuttle
dosimeter technique assuming the mis-positioning of dosimeters in a range of 1 to 5 cm
in the z-direction (upper) from the original positions. Figure 5 and Figure 6 demonstrate


























inaccurately determined positioning of the D-shuttle dosimeters on the NEMA body
phantom, respectively. It is clearly seen in the both figures, most of the box’s locations
are on the –y-axis, which indicates the underestimated results due to the mis-located
dosimeters. Because the mis-located D-shuttle dosimeter positions on the NEMA body
phantom  surface  were  far  from the  six  radioactive  spheres  when  compared  to  the
original positions, the estimated surface doses at each mis-located position of the D-
shuttle dosimeter were lower than the measured surface doses at the original positions.
Thus, we obtained this underestimation in the cumulative radioactivity and the absorbed
doses of the torso cavity and six spheres. As shown in Fig. 5, the obtained average
cumulative radioactivity of the torso cavity and six spheres were overestimated until 3
mis-located  D-shuttle  dosimeters  in  a  range  of  0.25%  to  22.9%  and  then  it  was
underestimated due to 4 to 11 mis-located D-shuttle dosimeters as high as 49.0% at the
5 cm shifted position. It is also clearly seen in Fig. 6, the obtained average absorbed
doses (i.e., effective doses) were overestimated until 3 mis-located D-shuttle dosimeters
in a range of 0.01% to 20.6% and then it was underestimated as high as 71.3% at the 5
cm shifted position.  As shown in Fig. 7, the estimated absorbed doses in two small
spheres (i.e., 17 mm and 10 mm spheres) were overestimated by 28% in the 17 mm
sphere  and  24%  in  the  10  mm  sphere.  Therefore,  the  calculated  effective  doses
(averaging doses of all targets) for less mis-locations (D1, D1 to D2, and D1 to D3)
were overestimated in this study. For other cases, the overestimation of absorbed doses
for lower radioactive spheres was lower than the underestimation of absorbed doses for
other radioactive spheres, which resulted in the underestimation of the effective dose.

























dosimeters.  It  is  also  apparent  that  the  cumulative  radioactivities  have  a  higher
maximum and a larger range than the absorbed doses (see Figure 5 and Figure 6). 
To apply the D-shuttle  technique in a clinical  PET study, we must take into
account  of  the  mis-locations  of  D-shuttle  dosimeter  positions.  Although  we  will
consider the personal outfit of figure for each patient, mis-positioning of the D-shuttle
dosimeter will not be avoidable if CT or MRI procedures are not available. Ficaro et al.
[22] stated that “anatomic differences between the respective anthropormic phantoms
and individual patients introduce a dosimetric error, and an error value of 10% to 20%
is probably not inconsistent’’ and “recent data report that organ doses for individual
patients derived from reference dose coefficients are generally accurate to no better than
30% to 50% and variability may be as much as a factor of 2 or more.’’ The present
study showed that the 1 cm and 2 cm mis-location of D-shuttle dosimeters attached to
the NEMA body surface from the original positions introduced an error of the effective
doses  of  -19.7% to  2.70% and -35.8% to  4.90%,  respectively  (see  Figure 6(a)  and
Figure  6(b)),  which  suggests  error  due  to  the  2  cm  mis-location  of  the  D-shuttle
dosimeter may be in an acceptable range for practical use. Further studies are required
to determine  how many mis-located  D-shuttle  dosimeter  and how much mis-located
distance  would be acceptable  to  estimate  the  consistent  internal  radiation  dosimetry
when the D-shuttle dosimeter technique is applied in a clinical PET study. 
Cumulative radioactivities and absorbed doses in the torso cavity and six spheres
of the NEMA body phantom were estimated through whole-body dynamic PET imaging
and D-shuttle dosimeter techniques.  To calculate the cumulative radioactivities in the
torso cavity and six spheres, we did not consider that  biological excretion and uptake,


























techniques are in agreement with the actual values, as presented in Table 2 and Table 3.
We found some errors in the estimated cumulative radioactivity obtained from the D-
shuttle and the PET measurements, as high as 28% in the 17 mm sphere and 24% in the
10  mm  sphere,  and  26%  in  the  10  mm  sphere  and  20%  in  the  13  mm  sphere,
respectively. The errors in the absorbed dose estimates to these compartments for both
dosimetric approaches were almost the same as the calculated errors in the estimated
cumulative radioactivities. In general, less error was observed for larger source organs
for both dosimetric  techniques  in  the present  study. The ratio  of the absorbed dose
estimates in the torso cavity and six spheres of the NEMA body phantom obtained from
PET and D-shuttle measurements with actual values are shown in Figure 7. Most of the
ratios obtained from PET and D-shuttle measurements were in between 0.9 and 1.1, and
0.8 and 1.0, respectively. It is important to note that we also found the same trends for
cumulative radioactivity ratios for both dosimetric approaches (Figure is not shown).
We found the same trends and the same errors between the estimated absorbed doses
and cumulative radioactivities in the torso cavity and six spheres of the NEMA body
phantom for both dosimetric  approaches because the self-absorbed dose contribution
due to  energy deposit  by positron  in  the  target  sphere is  greater  than  99% and the
absorbed dose contribution due to the photon interactions from the neighboring spheres
to the target sphere is less than 1% in this study. Because areas of low radioactivity
appear less intense and form inconspicuous PET images due to the partial volume effect
in the PET image, we obtained inconspicuous images for the 10 mm sphere, 13 mm
sphere,  and 17 mm sphere (see Figure 4). Thus, underestimations  with larger errors
were found for small source organs such as 10 mm sphere, 13 mm sphere, and 17 mm


























radioactivity,  we obtained the over estimation  with the larger  error for this  smallest
source organ through D-shuttle measurement. Interestingly, the overestimation with the
largest error was found for the 17 mm sphere,  although a consistent estimation was
obtained for the 13 mm sphere through D-shuttle measurements. This phenomenon may
have occurred because of the number of contributed D-shuttle dosimeters for the 17 mm
sphere was more compared to that for the 13 mm sphere. The bias in the estimated
effective dose from PET measurement and D-shuttle measurement were 14% and 7%,
respectively.  Owing  to  the  partial  volume  effect  in  PET  imaging,  the  bias  in  the
estimated  effective  dose obtained from PET measurement  was twice  that  of  the D-
shuttle measurement in this study. D-shuttle dosimeter technique does not have issue of
partial volume effect. 
There are some limitations in this study. First, the NEMA body phantom does
not contain bone structures. Second, the weighting factors for all regions in the NEMA
body  phantom  are  same.  Third,  there  is  no  biological  excretion  and  uptake,  only
physical decay dominates in this study. 
5 Conclusion
The inaccurate determination of the D-shuttle dosimeter positioning on the patient body
surface  may lead  to  inaccuracies  in  the  internal  radiation  dosimetry  estimation  in  a
clinical  PET study.  The present  study evaluated  the  errors  associated  with the mis-
location of D-shuttle dosimeters attached to a NEMA body phantom and showed that

























resulted in -19.7% and -35.8% bias in effective dose, respectively. We also compared
estimated doses by the D-shuttle dosimeter technique and the whole-body dynamic PET
imaging technique. The estimated internal radiation doses by two techniques were close
to  the  actual  (true)  values.  The  D-shuttle  measurement  showed  overestimation  and
underestimation due to internal radioactivity and geometric dependency, while the PET
measurement showed only underestimation due to the partial volume effect. 
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